Enantioselective Pd-Catalysed Nucleophilic C(sp3)-H (Radio)fluorination
- PMID: 40893403
- PMCID: PMC12393139
- DOI: 10.1038/s41929-025-01366-x
Enantioselective Pd-Catalysed Nucleophilic C(sp3)-H (Radio)fluorination
Abstract
Despite increasing demand for chiral fluorinated organic molecules, enantioselective C-H fluorination remains among the most challenging and sought-after transformations in organic synthesis. Furthermore, utilizing nucleophilic sources of fluorine is especially desirable for 18F-radiolabelling. To date, methods for enantioselective nucleophilic fluorination of inert C(sp3)-H bonds remain unknown. Herein, we report our design and development of a Pd-based catalytic system bearing bifunctional MPASA ligands which enabled highly regio- and enantioselective nucleophilic β-C(sp3)-H fluorination of synthetically important amides and lactams, commonly present in medicinal targets. The enantioenriched fluorinated products can be rapidly converted to corresponding chiral amines and ketones which are building blocks for a wide range of bioactive scaffolds. Mechanistic studies suggest that the C-F bond formation proceeds via outer-sphere reductive elimination with direct incorporation of fluoride, which was applied to late-stage 18F-radiolabelling of pharmaceutical derivatives using [18F]KF.
Conflict of interest statement
Competing interests: N. C., D. Q. P., Y. O., and J.-Q.Y. are inventors on a patent application related to this work (USSN Patent Application 63/797,339) filed by The Scripps Research Institute. D. J. D, K.-S. Y., and J. X. Q. are employees of Bristol Myers Squibb. The authors declare no other competing interests.
Figures






References
-
- Müller K, Faeh C & Diederich F Fluorine in pharmaceuticals: Looking beyond intuition. Science 317, 1881–1886 (2007). - PubMed
-
- Purser S, Moore PR, Swallow S & Gouverneur V Fluorine in medicinal chemistry. Chem. Soc. Rev 37, 320–330 (2008). - PubMed
-
- Gillis EP, Eastman KJ, Hill MD, Donnelly DJ & Meanwell NA Applications of Fluorine in Medicinal Chemistry. J. Med. Chem 58, 8315–8359 (2015). - PubMed
-
- Wang Q et al. FDA approved fluorine-containing drugs in 2023. Chinese Chemical Letters 109780 (2024).
Grants and funding
LinkOut - more resources
Full Text Sources